Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.49 |
| ▸ | ALPI | P09923 | 1/20 | 0.49 |
| ▸ | ALPG | P10696 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | PLEC | Q15149 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 10/20 | 0.46 |
| ▸ | CA1 | P00915 | 8/20 | 0.46 |
| ▸ | CA2 | P00918 | 8/20 | 0.46 |
| ▸ | CA12 | O43570 | 6/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24943216 | 0.88 | USP2 (0.58) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL21430744 | 0.86 | ALB (0.56) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL24943567 | 0.86 | USP2 (0.52) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14076112 | 0.82 | CA9 (0.68) | CA9CA1CA2CA12CA14 | |
| SCHEMBL13598774 | 0.80 | CA9 (0.55) | USP2L3MBTL1CA9CA1CA2 | |
| SCHEMBL14806746 | 0.76 | CA9 (0.57) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL24943213 | 0.76 | USP2 (0.51) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20412474 | 0.76 | USP2 (0.51) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL13698023 | 0.76 | CA9 (0.60) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL107875 | 0.75 | USP2 (0.76) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240342295-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | THE UNIVERSITY OF MANCHESTER (GB) | 2024-10-17 | — | — | US | disclosed |
| EP-4377363-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | The University of Manchester (GB) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023006909-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | THE UNIVERSITY OF MANCHESTER (GB) | 2023-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342295-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | CHRM2, CMBL, H1-0 | USP2 514/4885L3MBTL1 392/4885MEN1 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.